ORIC Oric Pharmaceuticals Inc

Price (delayed)

$10.86

Market cap

$1.12B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.41

Enterprise value

$1.07B

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 30
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 9

ORIC Pharmaceuticalsis a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's lead product candidate, ORIC-101, is a potent and selective small molecule antagonist ...

Highlights
Oric Pharmaceuticals's equity has surged by 89% YoY and by 8% QoQ
The quick ratio has grown by 37% year-on-year and by 15% since the previous quarter
ORIC's net income is down by 4.4% since the previous quarter

Key stats

What are the main financial stats of ORIC

ORIC stock price

How has the Oric Pharmaceuticals stock price performed over time
Intraday
6.94%
1 week
21.89%
1 month
28.52%
1 year
7%
YTD
32.76%
QTD
-14.29%

Financial performance

How have Oric Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$149.91M
Net income
-$135.21M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 4.8% since the previous quarter and by 2.2% year-on-year
ORIC's net income is down by 4.4% since the previous quarter

Price vs fundamentals

How does ORIC's price correlate with its fundamentals

Growth

What is Oric Pharmaceuticals's growth rate over time

Valuation

What is Oric Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.62
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 25% year-on-year and by 4.1% since the previous quarter
Oric Pharmaceuticals's equity has surged by 89% YoY and by 8% QoQ
The stock's P/B is 29% more than its 5-year quarterly average of 1.9 but 6% less than its last 4 quarters average of 2.6

Efficiency

How efficient is Oric Pharmaceuticals business performance
Oric Pharmaceuticals's return on invested capital has increased by 34% YoY and by 10% QoQ
The return on equity is up by 31% year-on-year and by 9% since the previous quarter
The ROA is up by 28% year-on-year and by 8% since the previous quarter

Dividends

What is ORIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ORIC.

Financial health

How did Oric Pharmaceuticals financials performed over time
The total assets has surged by 80% year-on-year and by 7% since the previous quarter
The quick ratio has grown by 37% year-on-year and by 15% since the previous quarter
ORIC's debt is 100% smaller than its equity
Oric Pharmaceuticals's equity has surged by 89% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.